ATOSIBAN Labatec sol inj 6.75 mg/0.9ml 0.9 ml
7680691850011
CH-69185
G02CX01
09.01.2.
1 / 3
google
Details
- Product number
- 6918501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- atosibanum 6.75 mg ut atosibani acetas 7.16 mg, mannitolum, acidum hydrochloridum, natrii hydroxidum corresp. natrium 0.86 mg, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml.
Articles (1)
Atosiban Labatec 6.75 mg / 0.9 ml, solution injectable
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.75 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
7.16 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.86 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 69185
- Drug name
- Atosiban Labatec, solution injectable / solution à diluer pour perfusion
- Galenic form
- LSIN
- ATC Code
- G02CX01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/03/2024
- Authorization expiration date
- 03/03/2029
- IT number
- 09.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ATOSIBAN Labatec sol inj 6.75 mg/0.9ml 0.9 ml
- Description (DE)
- ATOSIBAN Labatec Inj Lös 6.75 mg/0.9ml 0.9 ml
- Market launch
- 04/03/2024
- Narcotic (BTM)
- No